You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Significance of Marginal Acute Inflammation for Stage

Completed
  • Inflammation
  • Colon Cancer
  • MAI detection
  • (no location specified)
Nov 11, 2023

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • ctDNA methylation dynamic monitoring
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 14, 2023

Seminoma Trial in Duesseldorf (Robot-assisted retroperitoneal lymph node dissection, Adjuvant therapy with one cycle of

Recruiting
  • Seminoma
  • Robot-assisted retroperitoneal lymph node dissection
  • Adjuvant therapy with one cycle of cisplatin, etoposide and bleomycin
  • Duesseldorf, Germany
    University Hospital of Duesseldorf
Nov 17, 2023

MRD Test in Common Risk Stage II Colorectal Cancer

Not yet recruiting
  • Stage II Colorectal Cancer
  • MRD test
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Mar 29, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +11 more
  • Acupressure Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 12, 2023

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Breast Cancer, Stage 0, Colorectal Cancer Stage I, Head Neck Cancer Stage I Trial (CaRE@Home intervention)

Not yet recruiting
  • Breast Cancer, Stage 0
  • +11 more
  • CaRE@Home intervention
  • (no location specified)
Jun 9, 2023

Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

Not yet recruiting
  • NSCLC
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Aug 6, 2023

    NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

    Recruiting
    • Non-small Cell Lung Cancer
    • SH-1028 tablets
    • Placebo SH-1028 tablets
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 6, 2023

    Stage II Melanoma Trial in Wollstonecraft (Relatlimab and nivolumab fixed dose combination (FDC))

    Not yet recruiting
    • Stage II Melanoma
    • Relatlimab and nivolumab fixed dose combination (FDC)
    • Wollstonecraft, New South Wales, Australia
      Melanoma Institute Australia
    Oct 26, 2022

    Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

    Recruiting
    • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • +4 more
    • Cemiplimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 17, 2023

    NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

    Recruiting
    • NSCLC
    • SBRT+LDRT
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Apr 2, 2023

    Osteonecrosis Due to Drugs, Jaw Trial in Besançon (Human Amniotic Membrane, Conventional/Standard treatment)

    Active, not recruiting
    • Osteonecrosis Due to Drugs, Jaw
    • Human Amniotic Membrane
    • Conventional/Standard treatment
    • Besançon, France
      CHU de Besancon
    Dec 21, 2022

    Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

    Not yet recruiting
    • Melanoma
    • (no location specified)
    Nov 22, 2023

    Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

    Active, not recruiting
    • Laryngeal Cancer Stage II
    • +3 more
    • Amsterdam, Netherlands
      The Netherlands Cancer Institute
    Sep 27, 2022

    Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

    Active, not recruiting
    • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
    • +22 more
    • External Beam Radiation Therapy
    • Orbital Radiation
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8 Trial in Seattle (procedure, other, behavioral)

    Not yet recruiting
    • Stage II Colorectal Cancer AJCC v8
    • Stage III Colorectal Cancer AJCC v8
    • Biospecimen Collection
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 26, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +8 more
    • Exercise Intervention
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Aug 29, 2023

    Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

    Active, not recruiting
    • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
    • +11 more
    • Washington, District of Columbia
    • +6 more
    Feb 2, 2023

    Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)

    Recruiting
    • Stage II-III Gastric Cancer
    • MRD-guided therapy
    • Jinan, Shandong, China
    • +4 more
    Nov 27, 2023

    Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

    Not yet recruiting
    • Breast Cancer
    • Cancer of the Breast
    • VENTANA MIB-1 Ki67 assay
    • +4 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 18, 2023

    Periodontitis Trial in Tanta (spirulina gel, SRP of all teeth)

    Completed
    • Periodontitis
    • spirulina gel
    • SRP of all teeth
    • Tanta, Egypt
      Kafrelsheikh University
    Aug 24, 2023

    Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
    • ZhengZhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Jun 18, 2023

    Tumors, Rectal Trial (Dostarlimab)

    Not yet recruiting
    • Neoplasms, Rectal
    • Dostarlimab
    • (no location specified)
    Feb 2, 2023